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Abstract
Background: Use of the Amplatzer septal occluder (ASO) for the closure of secundum atrial septal defect (ASD) has recently become 
the procedure of choice, while earlier the only treatment for ASD was surgical closure. This study compares the right ventricular indices 
of the ASO group with the surgical closure group one year after intervention in adults.
Methods: From January 2008 to February 2010, 38 patients with isolated atrial septal defect of the secundum type one year after 
  surgical (n = 20, age = 27 ± 4 years, 13 females, 7 males) or Amplatzer septal occluder closure (n = 18, age = 25 ± 4 years, 12 females, 
6 males) were studied. At the same time, thirty-one age-matched normal subjects (age = 26 ± 6 years, 23 females, 9 males) were included 
as the control group. Strain and strain rate of the right ventricle were measured.
Results: The mean values of strain of the midportion were −26% ± 11.7%, −8.9% ± 4.2%, and 24.5% ± 7.4% (P , 0.001). Strain rates 
of the midportion were −2.19 ± 0.6 s−1, −1.2 ± 0.4 s−1, −1.9 ± 0.6 s−1 (P , 0.001) in ASO, surgery, and control groups, respectively.
Conclusion: This study showed that the right ventricle might show better performance in the ASO than the surgery group in adults with 
ASD in midterm follow-up.
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Introduction
Atrial  septal  defect  (ASD)  is  an  anatomic  defect 
between  the  atrial  chambers  allowing  interatrial 
shunting, which accounts for 10% of congenital heart 
diseases at birth and as much as 30% to 40% in adults 
who present with congenital heart problems and often 
leads  to  a  shortened  life  expectancy  compared  to 
healthy subjects.1–5
ASD  that  results  in  the  right  atrial  and  right 
  ventricular volume overload should be closed. It has 
traditionally been considered the standard   treatment 
for this type of malformation for more than 45 years.6,7 
Since the first attempt in 1976 by King and Mills,8 
the  placement  of  an  atrial  septal  occluding  device 
has increasingly become the treatment of choice.9–12 
In  the  last  decade,  the  Amplatzer  septal  occluder 
(ASO, one of the commonly used devices) with its 
unique  design  had  replaced  surgical  ASD  closure 
as a   suitable treatment for secundum ASDs in most 
  pediatric centers.13,14 However, few reports studied the 
practicability, outcome, and efficacy of closing ASDs 
using this device in adults in comparison with surgery 
in the long term.15 So, this study compared function 
of the right ventricle one year after   percutaneous and 
isolated  surgical  closure  of  secundum  atrial  septal 
defect in adults.
Methods
Patients
The  retrospectively  studied  patients  with  isolated 
secundum ASD who had undergone surgical or device 
ASD closure 1 year earlier were matched by age and 
function of the right ventricle before the procedure 
based on echocardiographic indices between January 
2008 and February 2010.
The inclusion criteria for both groups included: 
1)  the  presence  of  a  secundum  ASD  (diameter 
of ,35 mm by echocardiography for both groups); 
2) a left-  to-right shunt with a Qp:Qs ratio of ,1.5:1 
or the presence of right ventricular volume   overload 
that can be assessed by echocardiography or catheter-
ization; 3) the presence of a distance of ,5 mm from 
the margins of the ASD to the coronary sinus, atrio-
ventricular valves, and right upper pulmonary vein 
as measured by echocardiography; 4) successful per-
cutaneous transcatheter occlusion or surgical occlu-
sion and there was no residual shunt, complications, 
and clinical cardiac dysfunction after   procedure; and 
5) patients had sinus rhythm before and after atrial 
septal defect   closure. Patients with other   congenital 
or  acquired  valvular  or  myocardial  disease  were 
excluded.  At  the  end,  20  patients  (27  ±  4  years, 
13 females, 7 males) were enrolled in the   surgery 
group and 18 (25 ± 4 years, 12 females, 6 males) 
in the device group. All patients had a transthoracic 
echocardiogram (TTE) that identified the defect and 
subsequently had a transesophageal echocardiogram 
(TOE) to assess the size of the defect and ensure its 
suitability for percutaneous closure.
Thirty-one age-matched normal subjects (26 ± 6 
years, 23 females, 9 males) were included with the 
following criteria: i) sinus rhythm on electrocardi-
ography  with  no  conduction  disorder;  ii)  absence 
of  coronary  artery  disease  in  left  ventricular  (LV) 
  segments, which was assessed by a normal hyperdy-
namic response in all segments of the left ventricle 
to dobutamine stress echocardiography (particularly 
in the inferior wall and basal segment of the inter-
ventricular septum); iii) absence of cardiovascular or 
other systemic disease; iv) absence of hypertension or 
diabetes mellitus; v) persons were not on medication 
that influenced cardiac function; vi) absence of left 
ventricular outflow tract (LVOT) cavity gradient by 
DSE; vii) normal function of the right ventricle and 
the left ventricle; and viii) Laboratory tests, including 
tests for triglycerides, total cholesterol, high-density 
lipoprotein cholesterol, creatinine, and glycosylated 
hemoglobin (HbA1c), were normal.
All participants gave written informed   consent for 
inclusion in the study. The study protocol was approved 
by the Ethics Committee of the Iran   University of 
Medical Sciences (Tehran, Islamic Republic of Iran).
Surgical closure of the ASD
Standard  ASD  repair  under  general  endotracheal 
anesthesia was performed for patients who   underwent 
surgical closure. The right atrium was opened after 
a sternotomy using moderate hypothermia at 30 °C, 
CPB  aortic  cross-clamping,  and  cold  crystalloid 
  cardioplegic arrest. The ASD was closed either by 
direct  suture  or  by  a  pericardial  or  Goretex  patch 
(W.L. Gore Associates, Flagstaff, Arizona). The pati-
ents routinely were extubated in the operating room 
and transferred to the intensive care unit (ICU) for 
36 h. Cefazolin (25 mg/kg) was administered intrave-
nously every 8 hours prophylactically until the chest right ventricle response one year after intervention
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tubes were removed. The patients were   discharged 
home after three to five days in the hospital,   depending 
on their clinical condition.
Transcatheter closure of the ASD
The device closure protocol and full description of the 
device has been reported in detail in an earlier paper.26 
Briefly, all procedures were performed under general 
anesthesia (Midazolam (0.1 mg/kg dose) and   ketamine 
(1 mg/kg dose) were used at the time of induction, and 
sevoflurane (0.5%) was administered for   anesthesia 
maintenance) with endotracheal   intubation and with 
continuous transesophageal echocardiographic (TEE) 
monitoring.  The  device  used  was  the ASO  (AGA 
Medical Corp., Golden   Valley,   Minnesota). Balloon-
sizing of the defect was performed using the   stationary 
dilation balloon-sizing method. A   sizing-balloon was 
inflated  with  diluted  contrast  under  fluoroscopic 
and  echocardiographic  guidance.  The  echocardio-
graphic guidance was   performed using either TEE or 
ICE guidance using the AcuNav catheter connected 
to  an  Aspen  echocardiographic  system    (Acuson 
  Corporation,  Mountain  View,  California)  until  the 
appearance  of  waisting  and  disappearance  of  left-
  to-right  shunt. A  dose  of  an  appropriate  antibiotic 
was given during the procedure and two doses at 8-h 
interval were given later. All patients were instructed 
about infective endocarditis prophylaxis for a total of 
6 months after device placement. Aspirin 3–5 mg/kg 
was initiated 72 h before closure and continued for 
8 months after the procedure.
echocardiography
Two-dimensional  (2D)  echocardiography,  M-mode 
and TDI (3-MHz probe; Vivid 7, General Electric, 
Horten, Norway) were carried out with the patient in 
the left lateral decubitus position at rest.
After  acquisition,  images  with  the  best  endo-
cardial  definition  were  selected  and  displayed  in 
a    quad-screen  format  alongside  the  corresponding 
baseline  images.  All  images  were  recorded  on 
  videotape and digitized in a continuous loop format 
for side-by-side analysis.
RVOT fs and S velocity (at right ventricle outflow 
tract annulus) were measured using the M-Mode of 
the RVOT in parasternal short-axis view and TDI of 
the basal and mid of the RV in the apical four-  chamber 
view, respectively.
Regional  longitudinal  deformation  (Strain  and 
strain Rate) was quantified in mid and basal ventri-
cular  for  free  wall  by  SRI.  From  the  mean  strain 
rate  (SR)  and  strain  data,  peak  systolic  strain  rate 
(SRsys) and systolic strain (strainsys) were calculated 
in the four-chamber views. Peak strainsys was defined 
as the magnitude of deformation from end diastole 
to  end  systole.  Three  cardiac  cycles  were  stored 
from each view in patients with sinus rhythm. Color 
  Doppler myocardial imaging data were analyzed with 
  dedicated software (TVI, GE Healthcare).
Statistical analysis
The sample t-test was used for comparison of paramet-
ric variables obtained before and after   intervention, 
Independent Student t-test was used for comparison 
of parametric variables between two groups and one-
way ANOVA for comparison of values of echocar-
diographic  indices  between  three  groups.  Data  are 
mean ± SD. P , 0.05 was   considered significant. All 
tests were done with SPSS 16.0   (Statistical Package 
for Social Sciences) for Microsoft Windows.
Results
Among 38 patients with ASD for 1 year, 20 patients 
(53%)  were  in  surgery  group  and  the  remaining 
Table 1. Baseline characteristic of surgery, ASO and control group before procedure.
AsO surgery control P value
number of patients 18 20 31
Age (years, mean ± SD) 25 ± 4 27 ± 4 26 ± 6 0.08
Female/male (n) 12/6 13/7 23/9
ASD size (mm, mean ± SD) 23.4 ± 3.2 24.7 ± 2 – 0.104
Weight (kg, mean ± SD) 68 ± 7 65 ± 7 71 ± 9
Qp:Qs ratio (mean ± SD) 1.9 ± 0.5 2.1 ± 0.7 – 0.09
Abbreviations: ASD, atrial septal defect; Qp:Qs, ratio of pulmonary to systemic blood flow; ASO, Amplatzer septal occluder.Samiei et al
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18 patients (47%) were in ASO group; also 31 healthy 
individuals were selected. Baseline characteristics of 
these three groups are shown in Table 1. One year 
after the procedure, all patients of surgery and ASO 
groups had a successful operation and no residual 
shunts were seen.
The mean values of RVOT fs was 63.9% ± 10%, 
58% ± 11%, and 63% ± 12% in surgery, ASO, and 
control groups, respectively; however, there was no 
significant  difference  between  these  three  groups 
(P = 0.184). When compared with ASO group, the sur-
gery group had smaller S velocity in the   base-  portion 
(4 ± 1.5 versus 9.7 ± 1.6, P , 0.001) and mid-portion 
(3.6 ± 2 versus 7.6 ± 1.5, P , 0.001) of the right 
ventricle.
In  the ASO  and  control  group,  all  the  regional 
deformation properties of the right ventricular free 
wall were significantly increased, compared with the 
surgery group in the two mid- and basal-segments 
(Table 2). Also, ASO groups showed normal function 
when compared with the surgery group.
Discussion
ASD is one of the most common congenital heart 
defects, and it has long been accepted that surgical 
or transcatheter repair is the treatment of choice.12,16 
There  are  increasing  reports  of  the  short-term 
  follow-up of ASD closure with the ASO or surgery in 
pediatrics. However, until now there have been few 
publications to compare mid-term follow-up results 
between ASO and surgery in adults.17 In this study, 
we observed that adults with ASD using ASO device 
showed better right ventricle response in mid-term 
follow-up than patients who underwent surgery.
Significant  left-to-right  shunt  in  patients  with 
ASD  causes  volume  overload18,19  and  it  may  lead 
to  delayed  right  ventricular  contraction,  abnormal 
septal motion, and many other problems of the right 
ventricle. Previous studies evaluated the RV geomet-
ric change response to ASD closure by the measure-
ment of a single RV dimension in a long- or short-axis 
view, or both.20,21 RV dimension does not adequately 
reflect the complex geometry of the RV and abnormal 
  function.  Measurement  of  myocardial  deformation 
(strain and strain rate) overcomes the limitation of the 
conventional tissue Doppler imaging (combination of 
functional and nonfunctional   segment for calculating 
TDI indices) and is used progressively by the practi-
tioner.22 This study is one of the few attempts to com-
pare mid-term performance of the right ventricle after 
surgery and ASO occlusion in patients with   previous 
ASD by the tissue Doppler derived strain rate. The 
most important result of using strain rate imaging was 
as follows: 1) in the surgery group, myocardial defor-
mation properties of the right ventricle were reduced, 
compared with control and device groups; 2) in the 
ASO group, myocardial deformation properties were 
not  significantly  different  from  the  control  group. 
Salvo and colleagues showed that transcatheter ASD 
closure is also associated with a less negative impact 
on right-and-left ventricular function as assessed by 
tissue Doppler imaging.23 The study by Durongpisitkul 
showed that ASO is better than surgery.24
This  difference  between  surgery  and ASO  may 
be due to the independent effect of cardiopulmonary 
bypass  on  right  ventricular  systolic  and  diastolic 
function and because right ventricle is particularly 
susceptible  to  the  problems  of  cardiopulmonary 
bypass and intraoperative ischemia.25
conclusion
This study showed that after mid-term follow–up, the 
right  ventricle  showed  better  performance  in ASO 
than in surgery group in adults with ASD and it may 
Table 2. The comparison of right ventricle deformation properties in 3 groups.
AsO 
(mean ± sD)
surgery 
(mean ± sD)
control 
(mean ± sD)
P value
Strain of basal segment (%) −26.7 ± 11.7 −8.9 ± 4.2 −24.5 ± 7.4 ,0.001
Strain of mid segment (%) −26.6 ± 12.2 −7.4 ± 3.1    −29 ± 7.1 ,0.001
Sr of basal segment (s−1)     − 2 ± 0.6    −1 ± 0.25  − 1.6 ± 0.67 ,0.001
Sr of mid segment (s−1)  − 2.1 ± 0.6 −1.2 ± 0.46  − 1.9 ± 0.6 ,0.001
Abbreviations: Strain, strain of peak systolic; Sr, strain rate of peak systolic.publish with Libertas Academica and 
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be better to choose ASO procedure for occlusion of 
atrial defect in adults.
Limitations
It may be better to measure diastolic echocardiographic 
indices than the systolic ones. Also, further study with 
a larger population and long-term   follow-up may lead 
to more accurate results.
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